A patient with terminal cancer is given an experimental treatment using an ultra-rare radioactive element. His cancer goes into complete remission. Using a particle accelerator, scientists perform modern alchemy to potentially save countless lives.
A rare radioactive element could revolutionize cancer treatment, and a team of scientists in Vancouver are on the case.
An incredibly rare isotope called Actinium-225 could revolutionize the way we treat cancer. Preliminary trials have obliterated cancer in patients given only weeks to live. There's only one problem: it's almost impossible to obtain. Today, most of our global supply comes from American radioactive waste, but it's barely enough to treat a handful of patients per year. Due to this shortage, it's been impossible to do a large-scale clinical trial. A team of researchers in Vancouver is trying to change that. At TRIUMF, the world’s largest cyclotron particle accelerator, which is owned by a consortium of 20 Canadian universities - scientists are looking at a new way to make Actinium-225 using leftover particles from the accelerator. If successful, Canada could become the global supplier of a brand new, lifesaving cancer treatment.
This project will be created by a small but dedicated team of producers. Together we have a wide breadth of experience that covers science communication, cinematography, motion graphics, production, and promotion.
Many British Columbians are unaware that the world’s largest cyclotron particle accelerator is located in Vancouver! This documentary will showcase the amazing scientific research going on in our own backyard!
Researchers dedicate decades of their lives to projects of this magnitude. By telling the story of that dedication, we can help build appreciation for their work.
TRIUMF is an incredible facility that is largely open to the public in the form of free tours, talks and events. This project will encourage audiences to go see the accelerator for themselves and learn more about all the work being done there.
Virtually everyone’s life has been impacted by cancer in some way, yet glimpses into the research driving future treatments are rare. This documentary will provide a look at the early stages of a very promising therapy, and the challenges that scientists face.
By showcasing the diverse team working on Actinium-225 production and treatment, this documentary will encourage young viewers to get excited about the scientific community and consider careers in science, technology, engineering, and mathematics.
This incredible story has received very little media attention. This documentary will be the most in-depth look into one of the most incredible and promising medical research projects into cancer treatment currently going on at the moment. The documentary will appeal to anyone curious to learn about cutting edge of scientific and medical research.
Tom van Kalken has over 5 years experience in producing scientific content for TV, radio and online. As well as working for Network Ten (Australia) and NPR (USA), Tom also runs the popular The Science of Everything YouTube channel. With a strong subscriber base and over 250 000 views. We will utilize this reach to promote the finished product.
Producers Lucas Kavanagh and Jesse Lupini have worked together for years on Double Blind, a series of science-focused podcasts and videos. They have a strong track record of promotion with their top video being viewed over 600 000 times.
TRIUMF has a strong mandate to, and track record of, promoting their researcher’s stories. This documentary will utilize both their local and wider networks, which include connections to twenty universities across Canada and similar laboratories around the world to reach a wide, international audience.